Snapshot img

Implantable Medical Devices Market Size 2025-2029

The implantable medical devices market size is forecast to increase by USD 35.9 billion at a CAGR of 5.9% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of chronic illnesses and advancements in technology, particularly the adoption of 3D printing for implantable devices. However, this market faces notable challenges that require strategic navigation for companies seeking to capitalize on its potential. Regulatory hurdles, including stringent approval processes and compliance requirements, impact adoption and increase costs for manufacturers. Furthermore, high surgery costs associated with implant procedures can limit accessibility for patients, despite the benefits of these advanced medical solutions. These devices, which include insulin pumps, cosmetic implants, orthopedic implants such as knee replacements and spinal implants, ventricular assist devices, neurostimulation devices, dental implants, and implantable MRI systems, are transforming healthcare services.
To succeed in this market, companies must focus on addressing these challenges through innovative strategies, such as streamlining regulatory approvals and collaborating with healthcare providers to offer affordable financing options for patients. By staying abreast of market trends and addressing these challenges effectively, companies can capitalize on the significant growth opportunities presented by the market.

What will be the Size of the Implantable Medical Devices Market during the forecast period?

Request Free Sample

The market is experiencing significant advancements, driven by the integration of technology and biocompatible materials to enhance patient care and improve surgical precision. Informed consent processes are being augmented through digital platforms, enabling more transparent communication between healthcare providers and patients. Biocompatible coatings and bioabsorbable materials are revolutionizing device development, making implants more personalized and aligned with outcomes-based reimbursement. Precision surgery is being advanced through image-guided procedures and augmented reality, while remote diagnostics and haptic feedback facilitate connected healthcare. Value-based care and regulatory affairs are shaping the industry, driving innovation in areas such as tissue engineering, stem cell therapy, and gene therapy. Additionally, the increasing prevalence of chronic diseases like diabetes and cardiovascular conditions necessitates the development of more advanced and cost-effective implantable medical devices for chronic disease management. The market is expected to witness significant growth in the coming years, particularly in areas such as extremities, cardiac pacemakers, and insulin pumps.
Device tracking and supply chain management are becoming essential components of the healthcare ecosystem, ensuring patient safety and efficient delivery of care. Wearable technology, mobile health apps, and smart implants are transforming patient portal access and remote patient management, enabling a more proactive and personalized approach to healthcare. Industry consolidation continues to shape the landscape, with companies focusing on technology adoption, clinical research, and additive manufacturing to stay competitive. Biometric monitoring and cognitive enhancement are also emerging trends, as healthcare moves towards a more holistic and patient-centric approach. The future of implantable medical devices lies in the intersection of technology, biomaterials science, and healthcare policy, as we strive to deliver safer, more effective, and more accessible healthcare solutions.

How is this Implantable Medical Devices Industry segmented?

The implantable medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Orthopedic implants
  Cardiovascular implants
  Ophthalmic implants
  Dental implants
  Others


End-user

  Hospitals
  Clinics
  Others


Material

  Metallic
  Ceramic
  Natural
  Polymeric


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Type Insights

The orthopedic implants segment is estimated to witness significant growth during the forecast period. Implantable devices, including medical implants and orthopedic implants, are transforming healthcare through advances in digital health, precision medicine, and biocompatible materials. Orthopedic implants, such as joint replacements, are essential for treating various conditions, including knee injuries, hip fractures, spinal injuries, joint

Europe Implantable Medical Devices Market is projected to grow around USD 89.7 billion in 2025 to USD 157.2 billion by 2031, at a CAGR of 9.6% during the forecast period.

USD 6594.55 Million in 2024; projected USD 12194.48 Million by 2033; CAGR 7.06%.

The Active Implantable Medical Devices Market Report is Segmented by Product Type (Pacemakers, Implantable Cardioverter-Defibrillators (ICD), and More), Application (Cardiovascular Disorders, Neurological Disorders, and More), Technology (Conventional Devices, and More), (end User (Hospitals, and More), Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

According to Cognitive Market Research, the global Implantable Medical Devices Market size will be USD 92514.5 million in 2025. It will expand at a compound annual growth rate (CAGR) of 6.50% from 2025 to 2033.

North America held the major market share for more than 37% of the global revenue with a market size of USD 34230.37 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2033.
Europe accounted for a market share of over 29% of the global revenue with a market size of USD 26829.21 million.
APAC held a market share of around 24% of the global revenue with a market size of USD 22203.48 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2033.
South America has a market share of more than 4% of the global revenue with a market size of USD 3515.55 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033.
Middle East had a market share of around 4.00% of the global revenue and was estimated at a market size of USD 3700.58 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2033.
Africa had a market share of around 2.20% of the global revenue and was estimated at a market size of USD 2035.32 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2033.
Cardiovascular Implants category is the fastest growing segment of the Implantable Medical Devices industry

Market Dynamics of Implantable Medical Devices Market

Key Drivers for Implantable Medical Devices Market

Growing Chronic Illness Prevalence Boost Market Growth

Improvements in active implanted medical devices, the rise in cardiovascular and neurological disorders, and the rapidly aging population are the main factors propelling the growth of the implantables medical device market. Additionally, the market is growing as a result of rising investments and funding to develop technologically improved goods, increasing awareness of and developments in medical implants, and an increase in the applications of neurostimulators. However, it is anticipated that the market expansions will be impeded by the high cost of implantation and the scarcity of skilled specialists in the medical procedures industry. On the other hand, the growing number of reimbursement policies presents a market potential for implantable medical devices. In 2017, 800,000 Americans lost their lives to cardiovasculars disease, according to the American College of Cardiology. In the United States, one person passes away from cardiovascular disease every 40 seconds. Heart failure and stroke are the next leading causes of CVD mortality, after coronary heart disease (CHD). According to the European Heart Network (EU), cardiovascular disease (CVD) claims the lives of 3.9 million individuals in Europe and more than 1.8 million in the EU each year. The market for implanted pacemakers is growing quickly due to increased R&D trends in developing markets and rising healthcare research and development spending.

https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/02/09/14/58/heart-disease-and-stroke-statistics-2017

The development of technology in developed countries Boosts The Need For Advanced Implantable Medical Devices To Boost Market Growth

The design and operation of these devices have been completely transformed by advances in materials science, miniaturization, biocompatibility, and sensor technology. For example, the creation of cutting-edge biomaterials like bioresorbable polymers and titanium alloys has improved the longevity and body integration of implants. Furthermore, real-time physiological parameter data collection and remote transmission to healthcare practitioners are now possible with implantable devices thanks to sensor technology and wireless connectivity. This feature facilitates prompt intervention, early problem detection, and remote monitoring.

Restraint Factor for the Implantable Medical Devices Market

One major barrier to the market for implantable medical devices is their high cost. These gadgets frequently require sophisticated materials, sophisticated technology, and a great deal of research and development, which raises the cost of production. The regulatory licensing process for these devices can also be costly and time-consuming, which raises the total cost even further. Patients' access may be restricted by high ...

The global implantable medical devices market size is forecast to rise from USD 101.62 billion in 2025 to USD 185.45 billion by 2035, advancing at a CAGR above 6.2%. Top companies operating in the industry include Medtronic, Abbott, Boston Scientific, Stryker, Zimmer Biomet, shaping competitive strategies across the sector.

The global active implantable medical devices market size was USD 25.76 billion in 2024 & is projected to grow from USD 27.65 billion in 2025 to USD 44.94 billion by 2033.
Report Scope:

The global implantable medical devices market is projected to reach a value of around USD 225.1 billion by 2033, growing at a CAGR of 6.1% over the forecast period of 2023-2033. Increasing prevalence of chronic diseases, rising geriatric population, and technological advancements are among the key factors driving the growth of this market. Cardiovascular implants, orthopedic implants, and ophthalmology implants are the major product segments in the market. Hospitals hold the largest share in the end-use segment, owing to the increasing number of surgical procedures and the presence of advanced healthcare infrastructure in these settings. North America dominates the market, followed by Europe and Asia Pacific. Technological advancements, such as the development of miniaturized and wireless devices, are expected to fuel the market growth in the coming years. These devices offer numerous benefits, including reduced invasiveness, improved patient outcomes, and lower healthcare costs. The increasing adoption of robotics in surgical procedures is also expected to contribute to the market growth, as it enables more precise and efficient implantation of medical devices. However, factors such as stringent regulatory requirements and high costs associated with implantable medical devices may restrain the market growth to some extent. Overall, the implantable medical devices market is anticipated to continue growing steadily in the future due to the rising demand for advanced healthcare solutions and the increasing prevalence of chronic diseases. The global implantable medical devices market is projected to reach $150 billion by 2027, expanding at a CAGR of 7.5% during the forecast period. This growth can be attributed to the rising geriatric population, increasing prevalence of chronic diseases, and technological advancements in the field of medical devices. Recent developments include: In June 2024, BioHorizons, a dental implant company launched Tapered Pro Conical, which utilizes a tapered body and thread to provide stability. In addition, this implant can be used for single tooth and full arch dental implants , In June 2024, Royal Philips implanted the Duo Venous Stent System, an advanced medical device crafted to address symptomatic venous outflow obstruction in individuals suffering from chronic venous insufficiency. This achievement follows the device's premarket approval by the U.S. Food and Drug Administration, marking a significant advancement in treatment options for affected patients , In November 2023, Medtronic received FDA approval for its Symplicity Spyral renal denervation system, for treating hypertension. The minimally invasive procedure uses radiofrequency energy to calm overactive kidney nerves, which can contribute to high blood pressure .

Europe Implantable Devices Market is projected to grow from USD 102.4 billion in 2025 to USD 178.9 billion by 2031, at a CAGR of 9.6%.

Explore the booming Medical Implants market analysis for 2025-2033, driven by aging populations and technological advancements. Discover market size, CAGR, key drivers, and regional growth trends.

The Implantable Biomaterials market is booming, projected to reach $5.16 billion by 2033, fueled by aging populations and advancements in minimally invasive surgery. Explore market size, CAGR, key segments (cardiovascular, orthopedic, dental), leading companies, and regional trends in this comprehensive analysis.

The global market for polymers in implantable medical devices is booming, projected to reach $1482 million by 2025 with a 3.7% CAGR. Discover key trends, driving factors, and leading companies shaping this rapidly growing sector. Explore market segmentation by application and polymer type.

Implantable Medical Chip Market Outlook

According to our latest research, the global implantable medical chip market size is estimated at USD 7.6 billion in 2024. The market is experiencing robust growth, driven by technological advancements and increasing healthcare digitization, with a projected CAGR of 9.2% from 2025 to 2033. By the end of 2033, the market is forecasted to reach approximately USD 17.2 billion. The primary growth factor for the implantable medical chip market is the rising demand for real-time patient monitoring and personalized healthcare solutions, which is being fueled by a global surge in chronic diseases and the need for more efficient healthcare delivery.

The growth trajectory of the implantable medical chip market is being significantly influenced by the increasing prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and neurological disorders. These conditions necessitate continuous monitoring and timely intervention, which implantable medical chips can efficiently provide. The integration of advanced biosensor and microprocessor technologies into these chips enables healthcare professionals to monitor patients in real time, leading to improved patient outcomes and reduced hospitalization rates. Furthermore, the growing geriatric population worldwide, which is more susceptible to chronic diseases, is also contributing to the rising adoption of implantable medical chips for long-term disease management and preventive care.

Technological innovation remains a key driver in the expansion of the implantable medical chip market. The development of miniaturized, biocompatible, and multifunctional chips has made it possible to embed these devices safely within the human body, minimizing risks and maximizing clinical utility. Innovations such as wireless communication capabilities, integration with mobile health platforms, and data encryption for enhanced security have further expanded the scope of applications for these chips. Additionally, collaborations between medical device manufacturers, technology companies, and research institutes are accelerating the pace of innovation, leading to the introduction of next-generation implantable chips that offer improved performance, longevity, and patient comfort.

The regulatory environment is also playing a pivotal role in shaping the growth of the implantable medical chip market. Regulatory agencies across major markets such as North America, Europe, and Asia Pacific are streamlining approval processes for implantable medical devices, which is reducing time-to-market for new products. This, coupled with increased investments in healthcare infrastructure and rising awareness among healthcare professionals and patients regarding the benefits of implantable medical chips, is driving market expansion. However, compliance with stringent safety and efficacy standards remains essential, as patient safety is paramount in the adoption of implantable technologies.

From a regional perspective, North America continues to lead the implantable medical chip market, accounting for the largest share in 2024. This dominance is attributed to the presence of advanced healthcare systems, high healthcare expenditure, and a strong focus on technological innovation. Europe follows closely, supported by favorable government initiatives and a growing emphasis on personalized medicine. The Asia Pacific region is expected to witness the highest growth rate over the forecast period, driven by increasing healthcare investments, rising patient awareness, and the rapid adoption of digital health technologies in countries such as China, Japan, and India. Latin America and the Middle East & Africa are also showing promising growth potential, albeit from a smaller base, as healthcare infrastructure continues to develop and access to advanced medical technologies improves.

The advent of Smart Orthopedic Implant Electronics marks a significant milestone in the realm of implantable medical chips. These advanced electronics are designed to enhance the functionality of orthopedic implants, providing real-time data on joint movement, stress, and load. By integrating sensors and microprocessors into orthopedic devices, healthcare providers can monitor the performance and condition of implants remotely, ensuring timely interventions and personalized

The global tissue-level implant market is experiencing robust growth, driven by the increasing prevalence of chronic diseases requiring implantation procedures, advancements in implant materials and designs leading to improved biocompatibility and longevity, and a rising geriatric population. The market is segmented by implant type (cardiovascular, dental, breast, facial, orthopedic, and others), application (hospitals, ambulatory surgical centers, specialized clinics), and geography. While precise market sizing data is not fully provided, a reasonable estimate based on comparable markets and reported CAGRs suggests a 2025 market value in the range of $15-20 billion. Considering a conservative CAGR of 7% (a common rate for medical device markets), this market is projected to reach $25-30 billion by 2033. This growth is propelled by technological innovations, such as 3D printing for customized implants and minimally invasive surgical techniques, which lead to reduced recovery times and improved patient outcomes. The North American market currently holds a significant share, attributed to high healthcare expenditure and advanced medical infrastructure. However, rapidly developing economies in Asia-Pacific and Europe are exhibiting significant growth potential and are anticipated to capture substantial market share in the forecast period, fueled by rising disposable incomes and increasing healthcare awareness. Challenges include the high cost of implants, stringent regulatory approvals, and the potential for implant-related complications. Furthermore, the market faces competition from alternative treatment options and the potential for biomaterial-related adverse events. However, ongoing research and development efforts, particularly in biocompatible materials and implant design, are expected to mitigate these challenges and drive continued market expansion. Key players in the market are leveraging their strong R&D capabilities and strategic partnerships to strengthen their market position and meet growing demand. The focus on personalized medicine, coupled with improved surgical techniques, is expected to further stimulate growth within this lucrative segment of the medical device industry.

The global passive implantable medical devices market is booming, projected to reach $85 billion by 2033, driven by aging populations and technological advancements. Explore market size, CAGR, key players (Medtronic, Abbott, Boston Scientific), and regional trends in this comprehensive analysis.

According to Cognitive Market Research, the global Cardiac Bio Implant Devices market size was USD 38514.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.20% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 15405.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 11554.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 8858.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 1925.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 770.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
The hospital segment is the dominant end-user in the Cardiac Bio Implant Devices Market, driven by the high volume of cardiac procedures performed in these settings

Market Dynamics of Cardiac Bio Implant Devices Market

Key Drivers for Cardiac Bio Implant Devices Market

Rising Prevalence of Cardiovascular Diseases to Boost Market Growth

The increasing prevalence of cardiovascular diseases (CVDs) is a major driver of the Cardiac Bio Implant Devices Market. With CVDs being one of the leading causes of death globally, the demand for advanced treatments, including bio-implantable devices, is rising. Factors such as unhealthy lifestyles, poor dietary habits, and a growing aging population are contributing to the surge in heart-related ailments. As a result, healthcare providers and patients alike are increasingly turning to bio-implant devices as effective solutions to manage and treat these conditions, fostering market growth. For instance, February 2021, Medtronic introduced the TYRX Absorbable Antibacterial Envelope. This unique, single-use envelope possesses antibacterial properties and is designed to support cardiac implantable electronic devices or implanted neurostimulators

Technological Advancements in Implantable Devices to Drive Market Growth

Innovations in medical technology, particularly in the development of cardiac bio implant devices, are a significant driver of market expansion. Advances in biomaterials, such as biocompatible materials and smart implants, have enhanced the functionality and longevity of cardiac implants, making them more effective and safer for patients. Moreover, the integration of technologies like 3D printing and minimally invasive procedures has revolutionized the field, providing better patient outcomes and reducing recovery times. These advancements are encouraging more patients to opt for such devices, propelling the market forward.

Restraint Factor for the Cardiac Bio Implant Devices Market

High Cost and Affordability Issues, will Limit Market Growth

One of the major restraints in the Cardiac Bio Implant Devices Market is the high cost associated with these advanced medical devices. Bio-implant devices, often made from high-quality, specialized materials and requiring complex manufacturing processes, are expensive. This makes them unaffordable for a significant portion of the population, particularly in developing regions where healthcare budgets are limited. Additionally, high device costs can lead to delays in treatment or the use of alternative, less effective therapies. This affordability issue remains a key challenge for widespread market adoption.

Impact of Covid-19 on the Cardiac Bio Implant Devices Market

Covid-19 pandemic had a significant impact on the Cardiac Bio Implant Devices Market, disrupting both the supply chain and healthcare systems globally. During the height of the pandemic, many non-essential medical procedures, including elective cardiac surgeries, were postponed or canceled due to overwhelmed hospitals and the need to prioritize COVID-19 patients. This led to a temporary decline in demand for cardiac implants. Additionally, manufacturing and distribution challenges, such as factory shutdowns and transportation delays, affected the availability of these devices....

Europe Artificial Organs & Bionic Implants Market size was valued at USD 8.05 Billion in 2023 and is projected to reach USD 13.79 Billion by 2031, growing at a CAGR of 7.35% from 2024 to 2031.

Europe Artificial Organs & Bionic Implants Market: Definition/Overview

Artificial organs and bionic implants are engineered devices designed to replace or augment the functions of natural organs in the human body. An artificial organ is typically a human- made device or tissue that is implanted or integrated into a person, interfacing with living tissue to restore normal physiological functions, such as an artificial heart or kidney. These organs can be mechanical, made from polymers and metals, or bioartificial, incorporating living cells and biodegradable materials.

Snapshot img

Cardiovascular Medical Devices Market Size 2025-2029

The cardiovascular medical devices market size is forecast to increase by USD 21.71 billion at a CAGR of 7.6% between 2024 and 2029.

The market is driven by the escalating incidence of cardiovascular diseases and the expansion of insurance providers' coverage for related treatments. Market players are responding with innovative business strategies, including product development and strategic collaborations, to capitalize on these opportunities. However, the high cost of cardiovascular procedures poses a significant challenge for both patients and providers, potentially limiting market growth. Artificial intelligence and wireless technologies, such as Al-based electrocardiograms, implantable loop recorders, and event monitors, are also gaining popularity for their ability to improve diagnostic accuracy and patient care.
Effective cost management and continuous innovation will be essential for market success. As the population ages and cardiovascular diseases become increasingly prevalent, companies must navigate this financial obstacle while maintaining quality and affordability to meet patient needs and remain competitive. Companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis.

What will be the Size of the Cardiovascular Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The Cardiovascular Devices Market encompasses diagnostic monitoring devices, surgical devices, and cardiology devices used to prevent and manage heart disorders, including cardiomyopathy, heart failure, stroke, and heart-related mortality. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, making this market crucial for addressing healthcare resources and improving patient outcomes. Emerging nations are increasingly investing in advanced cardiovascular devices, such as AI-based ECG technology and minimally invasive procedures, to reduce fatal conditions like heart failure and stroke. The market is witnessing significant trends, including the integration of artificial intelligence in diagnostics and the development of more sophisticated surgical devices, such as coronary artery stents.

Cardiovascular Diseases, including heart disorders and heart-related mortality, are major health concerns, and the demand for diagnostic monitoring devices, such as Holter monitors, is on the rise. The market's growth is driven by the need for early detection and effective management of cardiovascular conditions, as well as advancements in technology, such as minimally invasive procedures and AI-based electrocardiogram technology. The Cardiovascular Devices Market is expected to continue growing, as healthcare systems in both developed and emerging nations seek to improve patient care and reduce the burden of cardiovascular diseases. With advancements in technology and a growing focus on preventative care, the market is poised for continued growth and innovation.

How is this Cardiovascular Medical Devices Industry segmented?

The cardiovascular medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Diagnostic systems
  Surgical devices


Disease Type

  Coronary artery disease
  Arrhythmia
  Heart failure
  Structural heart disease
  Others


End-user

  Hospitals
  ASCs
  Specialty clinics
  Home healthcare settings
  Rehabilitation centers


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The Diagnostic systems segment is estimated to witness significant growth during the forecast period. The market encompasses a vast array of technologies and devices designed to diagnose, monitor, and treat heart disorders and diseases. This market includes innovative solutions such as AI-based electrocardiogram (ECG) technology, implantable loop recorders, cardiac CT scans, and minimally invasive procedures for detecting clogged arteries and assessing heart function. Valves, pacemakers, stents, Holter monitors, and electrosurgical procedures are among the essential cardiovascular devices used for treating various heart conditions. The World Health Organization reports that cardiovascular diseases (CVDs) are the leading cause of heart-related mortality worldwide. Fatal conditions like atrial fibrillation, stroke, and heart attacks n

Active Implantable Medical Devices Market, By Product Type (Cardiac Rhythm Management Devices, Neurostimulation Devices, Implantable Hearing Devices, Others), By Technology (Conventional, Radiofrequency, Rechargeable, MRI-compatible, Others), By Application (Cardiovascular, Neurological, Audiology, Ophthalmology, Gastroenterology, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), By Procedure (Minimally Invasive Procedures, Open Surgeries, Others), By Material (Metals, Polymers, Ceramics, Others), By Sales Channel (Direct Sales, Distributors, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.